Name | Prasinezumab |
---|
Description | Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research[1]. |
---|---|
Related Catalog | |
In Vitro | Prasinezumab 针对人 α-突触核蛋白羧基末端的表位。 Prasinezumab 以高亲和力与人类聚集的 α-突触核蛋白结合[1]。 |
References |
No Any Chemical & Physical Properties |